Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,818
Closed -$2.44M 1771
2025
Q4
$2.44M Buy
+32,818
New +$2.4M 0.05% 521
2025
Q2
Sell
-37,220
Closed -$2.3M 1784
2025
Q1
$2.3M Buy
+37,220
New +$2.47M 0.16% 160
2024
Q4
Sell
-24,363
Closed -$1.98M 1392
2024
Q3
$1.98M Buy
+24,363
New +$1.95M 0.12% 212
2024
Q2
Sell
-66,910
Closed -$5.22M 1602
2024
Q1
$5.22M Buy
66,910
+46,329
+225% +$3.45M 0.39% 28
2023
Q4
$1.47M Sell
20,581
-335
-2% -$23.3K 0.14% 206
2023
Q3
$1.45M Buy
+20,916
New +$1.58M 0.14% 211
2023
Q2
Sell
-5,777
Closed -$466K 1461
2023
Q1
$466K Buy
+5,777
New +$465K 0.05% 563
2022
Q2
Sell
-24,895
Closed -$1.91M 995
2022
Q1
$1.91M Buy
24,895
+19,755
+384% +$1.42M 0.44% 35
2021
Q4
$394K Buy
+5,140
New +$378K 0.09% 315

Other funds holding HOLX

Y-Intercept (HK)'s HOLX Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Hologic (HOLX) in Q1 2026, closing a stake of 32,818 shares — an estimated $2.44M sold.

Y-Intercept (HK) first reported a position in HOLX in Q4 2021 and held it in 9 quarters. The position peaked at $5.22M in Q1 2024. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Y-Intercept (HK) reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 32,818 Hologic shares in Q1 2026, an estimated $2.44M.
  • Y-Intercept (HK) first reported a position in Hologic in Q4 2021 and held it in 9 quarters.
  • Y-Intercept (HK)'s Hologic position peaked at $5.22M in Q1 2024.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.